Lineage Cell Therapeutics Q3 EPS $(0.11) Misses $(0.05) Estimate, Sales $567K Miss $810K Estimate

Lineage Cell Therapeutics (AMEX:LCTX) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.05) by 120 percent. This is a 120.75 percent decrease over earnings of $0.53 per

Benzinga · 11/12/2019 21:32

Lineage Cell Therapeutics (AMEX:LCTX) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.05) by 120 percent. This is a 120.75 percent decrease over earnings of $0.53 per share from the same period last year. The company reported quarterly sales of $567 thousand which missed the analyst consensus estimate of $810 thousand by 30.00 percent. This is a 42.26 percent decrease over sales of $982 thousand the same period last year.